首页> 外文期刊>International Journal of Pharmaceutics >Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system.
【24h】

Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system.

机译:使用夹心渗透泵片剂系统同时递送硝苯地平和酒石酸美托洛尔。

获取原文
获取原文并翻译 | 示例
       

摘要

The sandwiched osmotic tablet system that could deliver Nifedipine and Metoprolol tartarate simultaneously for extended period of time was developed in order to reduce the problems associated with multidrug therapy of hypertension. This system composed of a middle push layer and attached drug layers of Nifedipine and Metoprolol. The advantage of the sandwiched osmotic tablet system over the commercialized push-pull osmotic tablet system is its simplicity of preparation, as the surface identification was avoided. Polyethylene oxide 600,000 and 8,000,000 g/mole were used as thickening agent of drug layer and the expandable hydrogel of push layer, respectively. It has been observed that amount of polyethylene oxide (PEO) and KCL of the drug and push layer had profound influence on Nifedipine and Metoprolol release. Further, the release of drugs was optimized by the size of the delivery orifice, level of plasticizer and membrane thickness. The optimal osmotic pump tablet was found to deliver both drugs at a rate of approximately zero order for up to 16 h independent of pH and agitational intensity, but dependent on the osmotic pressure of the release media. The formulations were found to be stable after 3 months of accelerated stability studies. Prediction of steady-state levels showed the plasma concentrations of Nifedipine and Metoprolol to be within the desired range. Further sandwiched system had a good sustained effect in comparison with the conventional product. Hence the prototype design of the system could be applied to other combinations of drugs used for cardiovascular diseases, diabetes, etc.
机译:为了减少与高血压的多药治疗有关的问题,开发了可以同时递送硝苯地平和酒石酸美托洛尔的夹心渗透片剂系统。该系统由硝苯地平和美托洛尔的中间推动层和附着的药物层组成。与商业化的推拉式渗透压片系统相比,夹心式渗透压片系统的优势在于其制备简单,因为避免了表面识别。分别使用600,000和8,000,000 g / mol的聚环氧乙烷作为药物层的增稠剂和推动层的可膨胀水凝胶。已经观察到,药物和推动层的聚环氧乙烷(PEO)和KCL的量对硝苯地平和美托洛尔的释放具有深远的影响。此外,通过释放孔的大小,增塑剂的含量和膜厚度来优化药物的释放。发现最佳的渗透泵片剂可在大约16个小时内以大约零级的速率输送两种药物,而与pH值和搅动强度无关,但取决于释放介质的渗透压。经过3个月的加速稳定性研究,发现该制剂稳定。对稳态水平的预测表明硝苯地平和美托洛尔的血浆浓度在所需范围内。与常规产品相比,进一步的夹心体系具有良好的持续效果。因此,该系统的原型设计可以应用于心血管疾病,糖尿病等药物的其他组合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号